April 28 (Reuters) - Merck & Co reported better than expected quarterly sales and earnings, helped by sales of its Januvia diabetes drug and its animal health products.
The U.S. drugmaker on Tuesday said it earned $953 million, or 33 cents per share, in the first quarter. That compared with $1.71 billion, or 57 cents per share, in the year earlier period.
14:29 Unilever rejects $143 billion Kraft Heinz bid as without merit19
16:08 Denzel Washington's Spot-On Parenting Advice For Amal And George Clooney17
15:21 Snap Set to Pitch $3.2 Billion Share Sale to Voteless Investors20
09:43 Austria sues Airbus, Eurofighter consortium over suspected fraud18